Despite different treatments and courses of illness, depressive symptoms appear similar in bipolar disorder (BD) and major depressive disorder (MDD), causing BD with an onset of depressive episode being frequently misdiagnosed as MDD, and leading to inappropriate treatment and poor clinical outcomes. Therefore, there is an urgent need to explore underlying neural basis to distinguish BD from MDD. The medical records of 80 first-episode, drug-naïve depressive patients with an initial diagnosis of MDD and illness duration of at least 5 years were reviewed retrospectively for this study. Fourteen bipolar depressed patients with a diagnosis conversion from MDD to BD, 14 patients with diagnosis of MDD, and 14 healthy subjects demographically matched with the BD group, were selected to participate in the study. Firstly, we examined whether there were differences among the three groups in whole brain fALFF during resting state. Secondly, clusters showing group differences in fALFF in any two groups were chosen as regions of interest (ROI) and then correlation between clinical features and fALFF values of ROIs were calculated. The BD group showed increased fALFF in bilateral putamen relative to both the MDD group and controls, while the MDD group exhibited decreased fALFF in left superior frontal gyrus (SFG) relative to both the BD group and controls (p < 0.05, corrected). Positive correlations between abnormality in the putamen and symptom severity were observed (significant for the MDD group, p = 0.043; marginally significant for the BD group, p = 0.060/0.076). These results implicate that abnormalities of key regions in the striatum and prefrontal areas may be trait markers for BD and MDD.
Citation: Zhang K, Liu Z, Cao X, Yang C, Xu Y, Xu T, et al. (2017) Amplitude of low-frequency fluctuations in first-episode, drug-naïve depressive patients: A 5-year retrospective study. PLoS ONE 12(4): e0174564. https://doi.org/10.1371/journal.pone.0174564
Editor: Klaus Ebmeier, University of Oxford, UNITED KINGDOM
Received: March 15, 2016; Accepted: March 12, 2017; Published: April 6, 2017
Copyright: © 2017 Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are available from figshare at: https://doi.org/10.6084/m9.figshare.4556530.v1
Funding: This study was funded by National Natural Science Foundation of China (No.81171290, 81471379, KZ. http://www.nsfc.gov.cn/) and the Natural Science Foundation for Young Scientists of Shanxi Province, China (No. 2012021036-2, XC. http://www.sxinfo.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Differences in clinical features between major depressive disorder (MDD) and bipolar disorder (BD) have been confirmed by epidemiologic and clinical studies. For example, compared with MDD, BD were characterized by lower lifelong prevalence (2.1% vs. 16.2%) [1,2], younger median age of onset (25 vs. 32 years) , and more depressive episodes . However, it is very difficult to distinguish MDD from BD, partially due to the fact that both of them show similar depressive episodes. It has been showed that approximately 60% of bipolar patients seeking treatment for depression are misdiagnosed as MDD or recurrent unipolar depression (UD) [5,6], leading to inappropriate prescription of antidepressants, increasing rate of switching to mania, and greater health care costs [7–9]. Therefore, there is a critical need to develop clinically objective biomarkers that could be used to discriminate BD from MDD.
Functional magnetic resonance imaging (fMRI) has been applied widely to identify potential neuropathphysiology of BD or MDD. Chen et al.  systematically reviewed the task-based fMRI literature on BD and found that BD exhibited underactivity in the inferior frontal cortex (IFG) and putamen, and overactivity in limbic areas (parahippocampal gyrus, hippocampus, amygdala and basal ganglia) relative to healthy controls. A meta-analysis  found that MDD showed overreactive salience network (amygdala, dorsal anterior cingulate cortex, and insula) and low response of dorsolateral prefrontal cortex and dorsal striatum to negative information. In addition, different brain activation patterns have been observed by directly comparing activations BD and MDD during performing a series of tasks (e.g., executive function [12,13], facial expressions [14–16], and reward ). However, the findings of these studies vary from the tasks performed by participants, posing a challenge to compare data obtained from different cognitive studies.
In the past decade, attention has been focused on functional abnormalities during task-free resting state in the neuroimaging field. The pioneering study by Biswal et al.  has revealed that spontaneous low frequency (0.01 ~ 0.08 Hz) fluctuations (LFF) in the resting state blood oxygen level dependent (BOLD) signal were highly synchronous among left and right motor cortices (i.e., resting state functional connectivity, RSFC). Abnormal LFF synchrony among remote brain areas has been reported in MDD (e.g., abnormal RSFC in cortico-limbic mood regulating circuit and default mode network [19–22]) and BD (e.g., disconnection in fronto-limbic circuit ). Moreover, different RSFC patterns have been found between BD and MDD in resting-state fMRI studies (e.g., [24–27]). However, these studies explored LFF from the perspective of temporal synchronization (i.e., RSFC), but neglected regional activity of MDD and BD during resting state.
The amplitude of LFF (ALFF) of BOLD signal, an index developed by  and calculated from the square root of power spectrum, was integrated in a low-frequency range, and reflects regional spontaneous neural activity of the brain. ALFF has been used widely to measure aberrant regional brain responses of various psychiatric disorders (e.g., ADHD , schizophrenia , BD , MDD [31,32]) during resting state. Since ALFF is sensitive to the physiological noise, Zou et al.  proposed an improved index named fractional ALFF (fALFF) approach, i.e., the ratio of power spectrum of low frequency to that of the entire frequency range. Herein, given the results of previous neuroimaging studies investigating similarities and discrepancy between BD and UD, we hypothesized that differences in fALFF may be found in regions belonging to cortical-limbic circuit and basal ganglia between first-episode medication-naïve depressed patients who later experienced manic/hypomanic episodes and those who never experienced manic/hypomanic episodes for same period of time. This study investigated the differences in fALFF between bipolar depressed patients with a diagnosis conversion from MDD to BD at the end of follow-up care period, major depressive patients with persistent diagnosis of MDD at the end of follow-up care period, and healthy controls in fALFF using a data-driven image analysis method. Apart from comparing fALFF between different clinical groups, we would further investigate the associations between clinical features and fALFF value of the regions showing group differences, and attempt to evaluate the potential of these regions to distinguish different groups.
Materials and methods
Written informed consent was obtained from each participant and consent from each participant’s guardian was also obtained prior to data acquisition. This study was approved by the Ethical Committee for Medicine of First Hospital of Shanxi Medical University, China.
First, we conducted a retrospective study that reviewed the medical records of 80 first-episode, drug-naïve depressive patients who were hospitalized in Department of Psychiatry, First Hospital of Shanxi Medical University in Taiyuan, China, between July 1, 2007 and December 31, 2009, with an initial diagnosis of MDD and no history of mania or hypomania. MDD diagnosis was based on the Chinese version of the Modified Structured Clinical Interview for DSM-IV, patient version (SCID-I/P) .
All participants (patients and health controls) included in this study needed to meet the following criteria: 1) be aged between 18 and 50 years; 2) right-handedness; 3) having no history of neurological illnesses or other severe diseases; and 4) having no history of head injury. Beyond that, the patient participants needed to satisfy four additional including criteria: 1) in their first episode and drug-naïve when they received the MRI scanning; 2) having at least 5 years of follow-up care as of January 1, 2015; 3) having been diagnosed with MDD or BP at the end of the 6 years follow-up; and 4) having a total score of 17-item Hamilton Depression rating scale (HAMD) not less than 17 during scanning. Exclusion criteria for the patients included comorbid neurological or psychological disorders, a diagnosis of a mood disorder due to a general medical condition, or a diagnosis that converted from MDD to another diagnosis other than BP. Half of the 80 patients met the aforementioned criteria.
Then, we followed up these 40 patients prospectively. They were reviewed every six month, the SCID-I/P diagnosis was redone during every visiting. After > 5 year follow-up care (range 5.02~7.40 years, 6.23 ± 0.66 years), 14 of them had experienced at least one manic/hypomanic episode, and their diagnosis was converted from MDD to BD (BD group, n = 14), 36 of them had experienced at least two major depressive episodes and had never experienced manic/hypomanic episodes. We further chose a subgroup of 14 patients from 36 MDD patients, matched age, gender and education-level with the BD group (MDD group, n = 14). There were no history of psychiatric illness in the health control participants and their first-degree relatives. The controls were demographically matched with the BD group (CON group, n = 14). Written informed consent was obtained from each participant and consent from each participant’s guardian was also obtained prior to data acquisition. The Ethical Committee for Medicine of the First Hospital of Shanxi Medical University approved this study.
Images were acquired using a Siemens Trio 3-Tesla scanner (Siemens, Erlangen, Germany). Foam pads and earplugs were used to limit head motion and reduce scanner noise. For each subject, resting-state functional data and a high-resolution T1-weighted anatomical image were acquired. Scanning parameters of the functional and structural images are as follows: 1) echo-planar imaging (EPI) sequence with 32 axial slices, repetition time (TR) = 2000 ms, echo time (TE) = 30 ms, thickness/skip = 3/1 mm, field of view (FOV) = 240×240 mm2, matrix = 64×64 mm2, flip angle (FA) = 90°, 212 volumes; 2) 3D T1-weighted magnetization-prepared rapid gradient echo (MPRAGE) sequence with 160 sagittal slices, TR = 2300 ms, TE = 2.95 ms, thickness/skip = 1.2/0.6 mm, FOV = 225×240 mm, matrix = 240×256 mm, FA = 9°, 160 volumes. During the resting state scan, subjects were instructed to close their eyes, and remain awake and as motionless as possible. After the resting state scans, all subjects were confirmed that they did not fall asleep during the scan.
Preprocessing and calculation of fALFF
Preprocessing and statistical analysis of the imaging data were carried out using Connectome Computation System (CCS: http://lfcd.psych.ac.cn/ccs.html) , which combines multiple modules MRI to provide a computational platform for brain connectome analysis. The data preprocessing was composed of anatomical and functional processing steps. The structural preprocessing steps included: 1) removal of MR image noise using a spatially adaptive non-local means filter [36,37]; 2) brain extraction using a hybrid watershed/surface deformation procedure; 3) automated segmentation of cerebrospinal fluid (CSF), white matter (WM) and deep gray matter (GM) volumetric structures as well as surface reconstruction; and 4) spatial normalization of individual anatomical images to MNI152 standard brain template. The functional preprocessing steps included: 1) removing the first 5 volumes from each scan to allow for signal equilibration; 2) despiking and slice timing correction; 3) motion correction; 4) 4D grand mean intensity normalization; 5) aligning individual functional images to individual anatomical image using the grey-white matter boundary-based registration (BBR) algorithm ; 6) registering individual functional images to MNI152 standard template; 7) regressing out the Friston-24 motion time series and mean signals of WM and CSF to reduce the effects of these confounding factors [39, 40]; 8) removing linear and quadratic trends; and 9) spatial smoothing with Gaussian Kernel (FWHM = 6 mm).
Following the preprocessing steps, a quality control procedure (QCP)  was conducted to ensure the quality of images. In brief, QCP produces screenshots for visually inspecting the quality of brain extraction, segmentation, cortical surface reconstruction, BBR-based registration and head motion. Additionally, the minimal cost value of boundary based registration (mcBBR) and the mean frame-wise displacement (mean FD)  were calculated for measuring registration quality and head motion, which were used as covariates in the following group analysis. One patient in the MDD group was excluded due to corruption of the resting-state fMRI data. Finally, 14 in the BD group, 13 in the MDD group and 14 in the CON group passed the QCP. More details about QCP can be found at http://lfcd.psych.ac.cn/ccs.html.
Subsequently, fALFF was computed in individual volume space within CCS. The amplitudes were calculated as square root of the power spectrum obtained at each frequency point. fALFF were calculated as the sum of amplitude in the range of 0.01 ~ 0.1 Hz divided by the total amplitude in the entire detectable frequency range, i.e., 0 ~ 0.25 Hz. The details of computation can be found in Zou et al. .
Demographic and clinical data comparisons.
One-way analysis of variance (ANOVA) was performed to examine whether there were differences among the three groups in age and years of education. Pearson Chi-square test was used to compare gender ratios. According to the distribution of data, two-sample t-test or Mann-Whitney U test were conducted to compare the total score of HAMD and the duration of illness between the two patient groups.
Whole brain fALFF analysis.
Group-level analyses of fALFF were conducted with FLAME in FSL using ordinary least squares (OLS) model. ANCOVA was first performed to investigate the differences among three groups followed by two-sample t-test for any two groups (BD-CON, MDD-CON and BD-MDD). Age, gender were included as covariates in all the group comparison models. In addition, mean FD and the minimal cost value during BBR (mcBBR) were applied as covariates to control the influences of registration and head motion. The resulting fALFF maps of group differences were threshold by Z > 2.3, corrected p < 0.05 using Gaussian Random Field theory. The significant clusters were defined as region of interested (ROIs) and extracted for the following analyses.
ROI-wise fALFF analysis.
The clusters showing significant differences in any two groups were defined as regions of interest (ROI). The mean fALFF values of the ROIs were extracted for each participant. Then one-way ANOVA and post-hoc analyses were performed respectively to compare differences of mean fALFF among the three groups and between each of the two groups.
Correlations with clinical variables.
In order to investigate the relationship between clinical variables and regional spontaneous brain activity during resting state, correlation analyses were performed between total score of HAMD, illness duration and the mean fALFF value of each ROI in two patient groups, controlling for the effect of age, gender and years of education. A two-tailed p level of 0.05 was used as the criterion of statistical significance.
Demographic and clinical data comparisons
Three groups were comparable in age, gender and years of education. There were no significant differences between the BD and MDD group in total score of HAMD and illness duration. Details of the results were listed in Table 1.
Whole brain fALFF analysis
One-way ANOVA revealed significant differences in left and right putamen as well as left superior frontal gyrus (SFG) among three groups (p < 0.05, corrected) (Table 2). Then two-sample t-tests were performed for each pair of groups. For the BD vs. CON comparison, significantly increased fALFF in bilateral putamen was observed in the BD group relative to the CON group. For the MDD vs. CON comparison, MDD showed significantly lower fALFF in left SFG extending to medial frontal gyrus (MFG) than CON group. For the BD vs. MDD comparison, the BD group exhibited significantly increased fALFF values in left SFG and bilateral putamen relative to the MDD group. Details of the results are given in Fig 1 and Table 2.
(A) demonstrates regions showing group difference between the BD and CON groups, with the fALFF value increased in BD relative to the controls. (B) demonstrates the region exhibiting group difference between the MDD and CON group, with the fALFF value increased in the CON group relative to MDD.(C) demonstrates regions showing group difference between the BD and MDD groups, with the fALFF value increased in BD relative to MDD. The color bar means the intensity of Z-value, yellow/red in the color bar denotes relatively higher fALFF values, and cyan /blue in the color bar denotes relatively higher fALFF values. Locations of the clusters showing group differences were indicated by Arabic numbers labeled in each image. The number in the lower right corner of each image refers to the z MNI coordinates. Brain region labels: 1. left putamen; 2. right putamen; 3. left superior frontal gyrus/medial frontal gyrus; 4. right putamen; 5. left putamen; 6. left superior frontal gyrus. Left in the figure indicates the right side of the brain. BD: bipolar disorder. MDD: major depression. CON: control.
ROI-wise fALFF analysis
Clusters showing significant group differences were chosen as ROI to verify fALFF differences across groups. There were six ROIs in total (see Fig 1 and Table 2): 1) left putamen resulted from the BD-CON comparison (L PUTBD-CON); 2) right putamen resulted from the BD-CON comparison (R PUTBD-CON); 3) left SFG/MFG resulted from the MDD-CON comparison (L SFG MDD-CON); 4) right putamen resulted from the BD-MDD comparison (R PUTBD-MDD); 5) left putamen resulted from the BD-MDD comparison (L PUTBD-MDD); and 6) left SFG resulted from the BD-MDD comparison (L SFG BD-MDD).
Subsequently, a mean fALFF value was calculated by averaging fALFF values of all the voxels in each ROI individually. One-way ANOVA revealed significant differences among the three groups in every ROI: L PUT BD-CON, F = 9.191, p = 0.001; R PUT BD-CON, F = 7.897, p = 0.001; L SFG MDD-CON, F = 13.091, p < 0.001; R PUT BD-MDD, F = 8.734, p = 0.001; L PUT BD-MDD, F = 10.088, p < 0.001; L SFG BD-MDD, F = 15.972, p < 0.001.
Then post-hoc analyses using Bonferroni correction were performed. We found that the BD group showed significantly higher mean fALFF value in bilateral putamen than both the MDD group (L PUT BD-CON, p = 0.002; R PUT BD-CON, p = 0.002; L PUT BD-MDD, p < 0.001; R PUT BD-MDD, p = 0.001) and CON group (L PUT BD-CON, p = 0.002; R PUT BD-CON, p = 0.003; L PUT BD-MDD, p = 0.005; R PUT BD-MDD, p = 0.019). In addition, the MDD group demonstrated significantly lower mean fALFF value in left superior frontal area than both the BD group (L SFG MDD-CON, p = 0.001; L SFG BD-MDD, p < 0.001) and CON group (L SFG MDD-CON, p < 0.001; L SFG BD-MDD, p < 0.001). These results are presented in Fig 2.
Distinct ROIs were presented in the X-axis. The Y-axis represented mean fALFF value of each ROI. A single asterisks means a significance level of p < 0.05, and double asterisks indicate a significance level of p <0.01. BD: bipolar disorder. MDD:. CON: control. L PUT BD-CON: left putamen resulted from BD vs. CON comparison; R PUT BD-CON: right putamen resulted from BD vs. CON comparison; L SFG MDD-CON: left SFG/medial frontal gyrus resulted from MDD vs. CON comparison; R PUT BD-MDD: right putamen resulted from BD vs. MDD comparison; L PUT BD-MDD: left putamen resulted from BD vs. MDD comparison; L SFG BD-MDD: left SFG resulted from BD vs. MDD comparison.
Correlations with clinical variables
Partial correlation analyses were utilized to investigate possible association between clinical characteristics and mean fALFF of the ROI showing significant group differences, controlling for the effect of age, gender and education level. No significant correlation was found between illness duration and mean fALFF of the six ROIs. However, in the MDD group, significant positive correlation was found between the total score of HAMD and mean fALFF of left putamen (L PUT BD-MDD, r = 0.647, p = 0.043). Besides, in the BD group, marginally significant positive correlations were found between the total score of HAMD and the mean fALFF value of bilateral putamen (L PUT BD-CON, r = 0.583, p = 0.060; the R PUT BD-CON, r = 0.555, p = 0.076).
In the present study, we retrospectively studied a group of first-episode medication-naïve patients with a diagnosis of MDD. For at least 5 years after onset of the illness, one subgroup was diagnosed as BD and the other subgroup maintained the diagnosis of MDD. We examined the resting-state fALFF within the whole brain to identify brain regions displaying activity differences among the three groups. We observed that, compared to both the MDD and CON, the BD group showed increased fALFF in bilateral putamen, while the MDD group exhibited decreased fALFF in left SFG relative to the other two groups (p < 0.05, corrected). Subsequent ROI analyses confirmed that these regions reflected brain abnormalities specific to different groups. ROC analysis further revealed acceptable performance (with sensitivity and specificity higher than 70% in general) of the putamen and SFG in identifying different groups. Finally, correlation analysis showed that significant positive correlations between fALFF in the putamen and symptom severity of MDD group (r = 0.647, p = 0.043).
Distinct bilateral putamen involvement in BD and MDD
Compared with both the MDD and CON groups, the BD group showed significantly increased fALFF in bilateral putamen, and no such difference was found between MDD and the CON groups. As an important component of the striatum, the putamen belongs to the lateral paralimbic system  and is interconnected with medial prefrontal cortex . Through functional connection with prefrontal cortex and subcortical limbic regions, the putamen is considered to be involved in processing emotional and motivational information [45,46].
Functional and structural abnormalities of the putamen in bipolar disorder have been reported in a number of studies. For fMRI studies, increased activation of the putamen has been observed in the BD patients during both task performing (e.g., emotional processing [47,48], response inhibition [49, 50], working memory [20, 51] and resting state (e.g., increased ALFF ). For structural MRI studies, enlargement of the putamen has been commonly found in bipolar patients (e.g., [52–56], except for [57,58]). More importantly, there were evidences showed that this putamen abnormality in function (e.g., higher activity during performing emotional task ) and structure (e.g., increased volume ) among BD patients is not mood state-dependent, but trait-related. Additionally, greater activation of the putamen was found in various age groups (e.g., pediatric , adolescents ) and relatives (e.g., first-degree relatives , offspring  of the BD patients. A recent meta-analysis identified distinct patterns of basal ganglia (especially putamen and caudate) engagement for BD and MDD within the facial affect processing network . Specifically, BD patients expressed increased activation in the putamen and in the caudate in response to negative and positive facial expressions, respectively. In addition, patients with basal ganglia lesions may develop both manic and depressive symptoms [61, 62], suggesting possible role of putamen in the pathophysiology of BD.
Based on the above evidences and our findings, we suggested that the abnormality of the putamen might be a trait marker of BD, which might occur early in the course of the BD, and can be observed in bipolar patients in different clinical episode.
Distinct left SFG involvement in BD and MDD
The MDD group exhibited significantly decreased fALFF in left SFG relative to both the BD group and CON group, and no such difference was found between BD and the CON groups. SFG consists of the dorsal and medial prefrontal regions, and they were core nodes of executive control network (ECN) and default mode network (DMN), respectively . Moreover, previous studies have showed that the superior frontal white matter links the dorsolateral prefrontal cortex (a hub node of ECN) and anterior cingulate cortex (a hub node of DMN) with subcortical nuclei . We speculate that the dysfunction of SFG might hinder information exchange between internal (relative to DMN) and external (relative to ECN) environments, causing MDD to show a series of defects in mood management and cognitive control.
In line with our finding, both functional and structural abnormalities of the SFG among MDD patients have been observed in a large body of researches. Decreased activation in the SFG has been observed in the MDD patients during both task performing (e.g., reward processing ) and resting state (e.g., decreased ALFF ). Reduced local functional connectivity of SFG was found in first-episode, drug-naïve , treatment-resistant, and treatment-sensitive patients with depression . Moreover, our finding was supported by two recent meta-analyses. These meta-analysis were focused on task-based fMRI  and resting-state  studies, respectively, and the authors observed underactivation and underconnectivity in SFG among patients with MDD. In structural MRI studies, decreased volume of SFG has been reported consistently among MDD patients with different clinical characteristics (e.g., first-episode, medication-naïve MDD , treatment-resistant depression [71,72], remitted depression ).
Our subsequent ROC analysis showed SFG had better performance in discriminating BD from MDD and CON, with the AUC of the two ROIs (L SFG MDD-CON and L SFG BD-MDD) were 0.907 and 0.929, respectively. Consistent with our finding, two previous studies have observed that SFG could be used to classify MDD and healthy controls [69,74]. Based on the above evidences and our findings, we suggest that decreased activity in the left SFG might be associated with MDD.
Putamen activity association with depression severity
Correlation analyses revealed possible association between the fALFF value of putamen and total score of HAMD in MDD (left putamen, r = 0.647, p = 0.043) and BD (marginal significant, left putamen, r = 0.583, p = 0.060; right putamen, r = 0.555, p = 0.076) groups, indicating that the higher activity of the putamen in resting state, the more serious depressive symptoms in two patient groups. The basal ganglia (including putamen) might be involved in emotion control, and disrupting in basal ganglia-cortical connectivity may contribute to depressive symptom expression [75,76]. Because of the functional connection with prefrontal cortex and subcortical limbic regions, the putamen is considered to be involved in emotional and motivational processing [45,46].
As stated above, a large number of studies have reported that functional and structural abnormalities of the putamen in various age, different mood states of BD groups, ever relatives of BD patients also showed dysfunction in putamen. In contrast, there were only a few studies reported functional and structural abnormalities in the putamen among MDD patients. A structural MRI study observed that depressed patients had significantly smaller putamen nuclei compared with controls . The finding from a PET research showed that extracellular dopamine in bilateral putamen is lower in MDD subjects exhibiting motor retardation .
Although our results suggest that there is a potential clinical significance of putamen in mood disorders, they also raised a couple of questions to be addressed in future studies. For example, what happens in communicating between putamen, as a component of basal ganglia-cortical circuits, with other parts of the circuits among mood disorders? What are the common and distinct putamen engagements in the circuits between BD and MDD? Further structural and functional connectivity researches are warrant in this regard.
Several limitations of the current study should be addressed. Firstly, the sample size of each group was relatively small. Nevertheless, given the difficulty to obtain enough retrospective data, the evidence for early identification of BD provided by our results of the present study is valuable. With the continuation of our longitudinal study, analytical results based on larger sample size and stricter analysis (eg, multiple comparison correction) will be more reliable and more applicable for clinical practice. Secondly, the medical records of 80 first-episode, drug-naïve depressive patients with an initial diagnosis of MDD and illness duration of at least 5 years were retrospected for this study. Although this is quite a long period, it still cannot include all the potential patients in our dataset whose first episode was a depressive episode and may later switch to mania/hypomania. Thirdly, although our results implicate that alteration of putamen and SFG function may appear in early stage of BD and MDD respectively, we could not determine whether these functional abnormalities exist before or after illness onset. In future work, follow up of at-risk subjects (e.g., offspring or first-degree relatives of the patients with mood disorders) would be helpful to clarify this issue.
In summary, we found altered fALFF of the putamen and SFG in depressive patients who were in their first episode, which may respectively correspond to the possibility of developing BD or remaining diagnosis of MDD at least 5 years after the onset of illness. The impairments of resting-state function in the putamen and SFG may serve as biomarkers for early identification of BD and MDD. These results implicate that abnormalities of key regions in the striatum and prefrontal areas may be trait markers for BD and MDD respectively.
We sincerely thank the patients and the healthy volunteers for their participation, and the medical staff involved in the process of MRI data acquisition.
This study was funded by National Natural Science Foundation of China (No.81171290, 81471379) and the Natural Science Foundation for Young Scientists of Shanxi Province, China (No. 2012021036–2).
- Conceptualization: KZ.
- Data curation: ZL XC CY YX CX.
- Formal analysis: TX ZY.
- Funding acquisition: KZ.
- Investigation: ZL XC YX.
- Methodology: KZ YX.
- Project administration: YX.
- Resources: KZ YX.
- Software: TX ZY.
- Supervision: KZ.
- Validation: KZ.
- Visualization: KZ.
- Writing – original draft: XC.
- Writing – review & editing: ZL.
- 1. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003; 289: 3095–3105. pmid:12813115
- 2. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007; 64: 543–552. pmid:17485606
- 3. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62: 593–602. pmid:15939837
- 4. Perlis RH, Brown E, Baker RW, Nierenberg AA. Clinical features of bipolar depression versus major depressive disorder in large multicenter trials. Am J Psychiatry. 2006; 163: 225–231. pmid:16449475
- 5. Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry. 2003; 64: 161–174. pmid:12633125
- 6. Mathers C, Fat DM, Boerma JT. The global burden of disease: 2004 update: World Health Organization.2008.
- 7. Keck PE Jr., Kessler RC, Ross R. Clinical and economic effects of unrecognized or inadequately treated bipolar disorder. J Psychiatr Pract 14 Suppl. 2008; 2: 31–38.
- 8. Baldessarini RJ, Salvatore P, Khalsa HM, Gebre-Medhin P, Imaz H, González-Pinto A. Morbidity in 303 first-episode bipolar I disorder patients. Bipolar Disord. 2010; 12: 264–270. pmid:20565433
- 9. Valenti M, Pacchiarotti I, Bonnin CM, Rosa AR, Popovic D, Nivoli AM. Risk factors for antidepressant-related switch to mania. J Clin Psychiatry. 2012; 73: e271–276. pmid:22401488
- 10. Chen CH, Suckling J, Lennox BR, Ooi C, Bullmore ET. A quantitative meta-analysis of fMRI studies in bipolar disorder. Bipolar Disord. 2011; 13: 1–15.
- 11. Hamilton JP, Etkin A, Furman DJ, Lemus MG, Johnson RF, Gotlib IH. Functional neuroimaging of major depressive disorder: a meta-analysis and new integration of base line activation and neural response data. Am J Psychiatry. 2012; 169: 693–703. pmid:22535198
- 12. Taylor Tavares JV, Clark L, Furey ML, Williams GB, Sahakian BJ, Drevets WC. Neural basis of abnormal response to negative feedback in unmedicated mood disorders. Neuroimage. 2008; 42: 1118–1126. pmid:18586109
- 13. Diler RS, Pan LA, Segreti A, Ladouceur CD, Forbes E, Cela SR, et al. Differential Anterior Cingulate Activity during Response Inhibition in Depressed Adolescents with Bipolar and Unipolar Major Depressive Disorder. J Can Acad Child Adolesc Psychiatry. 2014; 23: 10–19. pmid:24516473
- 14. Almeida JR, Versace A, Hassel S, Kupfer DJ, Phillips ML. Elevated amygdala activity to sad facial expressions: a state marker of bipolar but not unipolar depression. Biol Psychiatry. 2010; 67: 414–421. pmid:19931855
- 15. Diler RS, de Almeida JR, Ladouceur C, Birmaher B, Axelson D, Phillips M. Neural activity to intense positive versus negative stimuli can help differentiate bipolar disorder from unipolar major depressive disorder in depressed adolescents: a pilot fMRI study. Psychiatry Res. 2013; 214: 277–284. pmid:24080517
- 16. Fournier JC, Keener MT, Almeida J, Kronhaus DM, Phillips ML. Amygdala and whole-brain activity to emotional faces distinguishes major depressive disorder and bipolar disorder. Bipolar Disord. 2013; 15: 741–752. pmid:23911154
- 17. Bertocci MA, Bebko GM, Mullin BC, Langenecker SA, Ladouceur CD, Almeida JR, et al. Abnormal anterior cingulate cortical activity during emotional n-back task performance distinguishes bipolar from unipolar depressed females. Psychol Med. 2012; 42: 1417–1428. pmid:22099606
- 18. Biswal B, Yetkin FZ, Haughton VM, Hyde JS. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med. 1995; 34: 537–541. pmid:8524021
- 19. Wang L, Hermens DF, Hickie IB, Lagopoulos J. A systematic review of resting-state functional-MRI studies in major depression. J Affect Disord. 2012; 142: 6–12. pmid:22858266
- 20. Guo WB, Liu F, Xue ZM, Xu XJ, Wu RR, Ma CQ, et al. Alterations of the amplitude of low-frequency fluctuations in treatment-resistant and treatment-response depression: a resting-state fMRI study. Prog Neuropsychopharmacol Biol Psychiatry. 2012; 37(1):153–60. pmid:22306865
- 21. Liu F, Guo W, Liu L, Long Z, Ma C, Xue Z, et al. Abnormal amplitude low-frequency oscillations in medication-naive, first-episode patients with major depressive disorder: a resting-state fMRI study. J Affect Disord. 2013; 146(3):401–406. pmid:23116810
- 22. Guo WB, Liu F, Xun GL, Hu MR, Guo XF, Xiao CQ, et al. Reversal alterations of amplitude of low-frequency fluctuations in early and late onset, first-episode, drug-naive depression. Prog Neuropsychopharmacol Biol Psychiatry. 2013; 40:153–159. pmid:22960081
- 23. Radaelli D, Sferrazza Papa G, Vai B, Poletti S, Smeraldi E, Colombo C, et al.Fronto-limbic disconnection in bipolar disorder. Eur Psychiatry. 2015; 30: 82–88. pmid:24853295
- 24. Liu CH, Ma X, Wu X, Zhang Y, Zhou FC, Li F, et al.Regional homogeneity of resting-state brain abnormalities in bipolar and unipolar depression. Prog Neuropsychopharmacol Biol Psychiatry. 2013; 41: 52–59. pmid:23200830
- 25. He H, Yu Q, Du Y, Vergara V, Victor TA, Drevets WC, et al. Resting-state functional network connectivity in prefrontal regions differs between unmedicated patients with bipolar and major depressive disorders. J Affect Disord.2015; 190: 483–493. pmid:26551408
- 26. Marchand WR, Lee JN, Johnson S, Gale P, Thatcher J.Differences in functional connectivity in major depression versus bipolar II depression. J Affect Disord. 2013; 150: 527–532. pmid:23433856
- 27. Wang Y, Zhong S, Jia Y, Zhou Z, Wang B, Pan J, et al. Interhemispheric resting state functional connectivity abnormalities in unipolar depression and bipolar depression. Bipolar Disord. 2015; 17: 486–495. pmid:26241359
- 28. Zang YF, He Y, Zhu CZ, Cao QJ, Sui MQ,Liang M, et al. Altered baseline brain activity in children with ADHD revealed by resting-state functional MRI. Brain Dev. 2007; 29: 83–91. pmid:16919409
- 29. Hoptman MJ, Zuo XN, Butler PD, Javitt DC, D'Angelo D, Mauro CJ, et al. Amplitude of low-frequency oscillations in schizophrenia: a resting state fMRI study. Schizophr Res. 2010;117: 13–20. pmid:19854028
- 30. Xu K, Liu H, Li H, Tang Y, Womer F, Jiang X, et al. Amplitude of low-frequency fluctuations in bipolar disorder: a resting state fMRI study. J Affect Disord. 2014; 152–154: 237–242. pmid:24120087
- 31. Gong Y, Hao L, Zhang X, Zhou Y, Li J, Zhao Z, et al. Case-control resting-state fMRI study of brain functioning among adolescents with first-episode major depressive disorder. Shanghai Arch Psychiatry. 2014; 26: 207–215. pmid:25317007
- 32. Wang L, Dai W, Su Y, Wang G, Tan Y, Jin Z, et al. Amplitude of low-frequency oscillations in first-episode, treatment-naive patients with major depressive disorder: a resting-state functional MRI study. PLoS One. 2012; 7: e48658. pmid:23119084
- 33. Zou QH, Zhu CZ, Yang Y, Zuo XN, Long XY, Cao QJ, et al. An improved approach to detection of amplitude of low-frequency fluctuation (ALFF) for resting-state fMRI: fractional ALFF. J Neurosci Methods. 2008; 172: 137–141. pmid:18501969
- 34. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute.2002.
- 35. Xu T, Yang Z, Jiang L, Xing XX, Zuo XN. A Connectome Computation System for discovery science of brain. Science Bulletin. 2015; 60: 86–95.
- 36. Xing XX, Zhou YL, Adelstein JS, Zuo XN. PDE-based spatial smoothing: a practical demonstration of impacts on MRI brain extraction, tissue segmentation and registration. Magn Reson Imaging. 2011; 29: 731–738. pmid:21531104
- 37. Zuo XN, Xing XX.Effects of non-local diffusion on structural MRI preprocessing and default network mapping: statistical comparisons with isotropic/anisotropic diffusion. PLoS One. 2011; 6: e26703. pmid:22066005
- 38. Greve DN, Fischl B. Accurate and robust brain image alignment using boundary-based registration. Neuroimage. 2009; 48: 63–72. pmid:19573611
- 39. Yan CG, Craddock RC, Zuo XN, Zang YF, Milham MP. Standardizing the intrinsic brain: towards robust measurement of inter-individual variation in 1000 functional connectomes. Neuroimage. 2013; 80: 246–262. pmid:23631983
- 40. Friston KJ, Williams S, Howard R, Frackowiak RS, Turner R. Movement-related effects in fMRI time-series. Magn Reson Med. 1996; 35: 346–355. pmid:8699946
- 41. Jiang L, Xu T, He Y, Hou XH, Wang J, Cao XY, et al. Toward neurobiological characterization of functional homogeneity in the human cortex: regional variation, morphological association and functional covariance network organization. Brain Struct Funct. 2015; 220: 2485–2507. pmid:24903825
- 42. Power JD, Barnes KA, Snyder AZ, Schlaggar BL, Petersen SE. Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. Neuroimage. 2012; 59: 2142–2154. pmid:22019881
- 43. Kober H, Barrett LF, Joseph J, Bliss-Moreau E, Lindquist K, Wager TD. Functional grouping and cortical-subcortical interactions in emotion: a meta-analysis of neuroimaging studies. Neuroimage. 2008; 42: 998–1031. pmid:18579414
- 44. Ongur D, Price JL. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb Cortex. 2000; 10: 206–219. pmid:10731217
- 45. Surguladze S, Brammer MJ, Keedwell P, Giampietro V, Young AW, Travis MJ, et al. A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder. Biol Psychiatry. 2005; 57: 201–209. pmid:15691520
- 46. Strakowski SM, Delbello MP, Adler CM. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol Psychiatry. 2005; 10: 105–116. pmid:15340357
- 47. Surguladze SA, Marshall N, Schulze K, Hall MH, Walshe M, Bramon E, et al. Exaggerated neural response to emotional faces in patients with bipolar disorder and their first-degree relatives. Neuroimage. 2010; 53: 58–64. pmid:20595014
- 48. Hummer TA, Hulvershorn LA, Karne HS, Gunn AD, Wang Y, Anand A. Emotional response inhibition in bipolar disorder: a functional magnetic resonance imaging study of trait- and state-related abnormalities. Biol Psychiatry. 2013; 73: 136–143. pmid:22871393
- 49. Blumberg HP, Martin A, Kaufman J, Leung HC, Skudlarski P, Lacadie C, et al. Frontostriatal abnormalities in adolescents with bipolar disorder: preliminary observations from functional MRI. Am J Psychiatry. 2003; 160: 1345–1347. pmid:12832254
- 50. Pavuluri MN, Passarotti AM, Harral EM, Sweeney JA. Enhanced prefrontal function with pharmacotherapy on a response inhibition task in adolescent bipolar disorder. J Clin Psychiatry. 2010; 71: 1526–1534. pmid:20816040
- 51. Chang K, Adleman NE, Dienes K, Simeonova DI, Menon V, Reiss A. Anomalous prefrontal-subcortical activation in familial pediatric bipolar disorder: a functional magnetic resonance imaging investigation. Arch Gen Psychiatry. 2004; 61: 781–792. pmid:15289277
- 52. Noga JT, Vladar K, Torrey EF. A volumetric magnetic resonance imaging study of monozygotic twins discordant for bipolar disorder. Psychiatry Res. 2001; 106: 25–34. pmid:11231097
- 53. Strakowski SM, DelBello MP, Zimmerman ME, Getz GE, Mills NP, Ret J, et al. Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder. Am J Psychiatry. 2002; 159: 1841–1847. pmid:12411217
- 54. DelBello MP, Zimmerman ME, Mills NP, Getz GE, Strakowski SM. Magnetic resonance imaging analysis of amygdala and other subcortical brain regions in adolescents with bipolar disorder. Bipolar Disord. 2004; 6: 43–52. pmid:14996140
- 55. Chen Z, Cui L, Li M, Jiang L, Deng W, Ma X, et al. Voxel based morphometric and diffusion tensor imaging analysis in male bipolar patients with first-episode mania. Prog Neuropsychopharmacol Biol Psychiatry. 2012; 36: 231–238. pmid:22119745
- 56. Hallahan B, Newell J, Soares JC, Brambilla P, Strakowski SM, Fleck DE, et al. Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. Biol Psychiatry. 2011; 69: 326–335. pmid:21030008
- 57. Haller S, Xekardaki A, Delaloye C, Canuto A, Lovblad KO, Gold G, et al. Combined analysis of grey matter voxel-based morphometry and white matter tract-based spatial statistics in late-life bipolar disorder. J Psychiatry Neurosci. 2011; 36: 391–401. pmid:21284917
- 58. MacMaster FP, Carrey N, Langevin LM, Jaworska N, Crawford S. Disorder-specific volumetric brain difference in adolescent major depressive disorder and bipolar depression. Brain Imaging Behav. 2014; 8: 119–127. pmid:24158718
- 59. Deveney CM, Connolly ME, Jenkins SE, Kim P, Fromm SJ, Brotman MA, et al. Striatal dysfunction during failed motor inhibition in children at risk for bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2012; 38: 127–133. pmid:22414616
- 60. Delvecchio G, Fossati P, Boyer P, Brambilla P, Falkai P, Gruber O, et al. Common and distinct neural correlates of emotional processing in Bipolar Disorder and Major Depressive Disorder: a voxel-based meta-analysis of functional magnetic resonance imaging studies. Eur Neuropsychopharmacol. 2012; 22: 100–113. pmid:21820878
- 61. Robinson RG, Starkstein SE. Mood disorders following stroke: new findings and future directions. J Geriatr Psychiatry. 1989; 22: 1–15.
- 62. Starkstein SE, Mayberg HS, Berthier ML, Fedoroff P, Price TR, Dannals RF, et al. Mania after brain injury: neuroradiological and metabolic findings. Ann Neurol. 1990; 27: 652–659. pmid:2360802
- 63. Damoiseaux JS, Rombouts SA, Barkhof F, Scheltens P, Stam CJ, Smith SM, et al. Consistent resting-state networks across healthy subjects. Proc Natl Acad Sci U S A. 2006; 103: 13848–13853. pmid:16945915
- 64. Sexton CE, Mackay CE, Ebmeier KP. A systematic review of diffusion tensor imaging studies in affective disorders. Biol Psychiatry. 2009; 66: 814–823. pmid:19615671
- 65. Schiller CE, Minkel J, Smoski MJ, Dichter GS. Remitted major depression is characterized by reduced prefrontal cortex reactivity to reward loss. J Affect Disord. 2013; 151: 756–762. pmid:23835103
- 66. Wang L, Li K, Zhang Q, Zeng Y, Dai W, et al. (2014) Short-term effects of escitalopram on regional brain function in first-episode drug-naive patients with major depressive disorder assessed by resting-state functional magnetic resonance imaging. Psychol Med 44: 1417–1426. pmid:23942213
- 67. Guo WB, Liu F, Chen JD, Gao K, Xue ZM, Su Y, et al. Abnormal neural activity of brain regions in treatment-resistant and treatment-sensitive major depressive disorder: a resting-state fMRI study. J Psychiatr Res. 2012; 46: 1366–1373. pmid:22835912
- 68. Lai CH. Patterns of cortico-limbic activations during visual processing of sad faces in depression patients: a coordinate-based meta-analysis. J Neuropsychiatry Clin Neurosci. 2014; 26: 34–43. pmid:24275771
- 69. Sundermann B, Olde Lutke Beverborg M, Pfleiderer B. Toward literature-based feature selection for diagnostic classification: a meta-analysis of resting-state fMRI in depression. Front Hum Neurosci. 2014; 8: 692. pmid:25309382
- 70. Lai CH, Wu YT. Frontal-insula gray matter deficits in first-episode medication-naive patients with major depressive disorder. J Affect Disord. 2014; 160: 74–79. pmid:24445133
- 71. Machino A, Kunisato Y, Matsumoto T, Yoshimura S, Ueda K,Yamawaki Y, et al. Possible involvement of rumination in gray matter abnormalities in persistent symptoms of major depression: an exploratory magnetic resonance imaging voxel-based morphometry study. J Affect Disord. 2014; 168: 229–235. pmid:25064808
- 72. Jung J, Kang J, Won E, Nam K, Lee MS, Tae WS, et al. Impact of lingual gyrus volume on antidepressant response and neurocognitive functions in Major Depressive Disorder: a voxel-based morphometry study. J Affect Disord. 2014; 169: 179–187. pmid:25200096
- 73. Yuan Y, Zhu W, Zhang Z, Bai F, Yu H, Shi Y, et al. Regional gray matter changes are associated with cognitive deficits in remitted geriatric depression: an optimized voxel-based morphometry study. Biol Psychiatry. 2008; 64: 541–544. pmid:18550031
- 74. Qin J, Wei M, Liu H, Chen J, Yan R, Hua L, et al. Abnormal hubs of white matter networks in the frontal-parieto circuit contribute to depression discrimination via pattern classification. Magn Reson Imaging. 2014; 32: 1314–1320. pmid:25179136
- 75. Marchand WR, Lee JN, Suchy Y, Johnson S, Thatcher J, Gale P, et al. Aberrant functional connectivity of cortico-basal ganglia circuits in major depression. Neurosci Lett. 2012; 514: 86–90. pmid:22395089
- 76. Marchand WR. Cortico-basal ganglia circuitry: a review of key research and implications for functional connectivity studies of mood and anxiety disorders. Brain Struct Funct. 2010; 215: 73–96. pmid:20938681
- 77. Husain MM, McDonald WM, Doraiswamy PM, Figiel GS, Na C, Escalona PR, et al. A magnetic resonance imaging study of putamen nuclei in major depression. Psychiatry Res. 1991; 40: 95–99. pmid:1763144
- 78. Meyer JH, McNeely HE, Sagrati S, Boovariwala A, Martin K, Verhoeff NP, et al. Elevated putamen D2 receptor binding potential in major depression with motor retardation: an [11C]raclopride positron emission tomography study. Am J Psychiatry. 2006; 163: 1594–1602. pmid:16946186